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Implantation of a bioabsorbable vascular  
scaffold into a coronary vein graft:  
a two-week angiography follow-up
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An 83-year-old patient with a history of coronary artery bypass grafting (CABG) performed 13 years ago was admitted 
due to unstable angina for diagnostic catheterisation. His medical history consisted of CABG with left internal mammary 
artery to left anterior descending artery and vein grafts to obtuse margin artery (OM), diagonal artery (D1) and right 
coronary artery (RCA). Following that, the patient had multiple percutaneous coronary interventions (PCI) in vein grafts: 
bare metal stent implantation into the Ao-OM (three years ago), two POBA of Ao-OM (one and two years ago), two drug 
eluting stents (DES) into Ao-OM (six and 12 months ago), and DES into Ao-D1 (two years ago). Coronary angio graphy 
revealed significant stenosis in distal segment of Ao-RCA and in stent restenosis in DES implanted to Ao-OM. The lesion 
in Ao-RCA (% diameter stenosis = 82%, minimal diameter = 0.43 mm, lesion length = 5 mm) was treated with an 
everolimus-eluting bioabsorbable vascular scaffold (BVS) (Absorb, 2.5 × 15 mm) achieving good post procedural angio-
graphic results (% diameter stenosis = 13%, minimal diameter = 2.5 mm) (Fig. 1). Two weeks after the procedure, the 
patient was hospitalised again for an elective PCI of Ao-OM in stent restenosis. The bypass angiography revealed patent 
Ao-RCA with sustained good angiographic results at the site of BVS implantation. Drug eluting BVS implantation may 
be a new option for the treatment of stenotic coronary vein grafts. However, a prospective study is needed to validate 
the safety of such a BVS application.
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Figure 1. Two-week angiographic follow-up of the bioabsorbable vascular scaffold implantation into the vein graft of 
the right coronary artery; A. 82% stenosis of the right coronary vein graft (white arrow); B. The final effect of Absorb 
(2.5 × 18 mm) implantation into the right coronary vein graft (white dashed lines); C. Two-week follow-up of the Absorb 
stent implantation into the vein graft (white dashed lines)
A B C
